Biotech Patent Drawing Examples for Sequences and Constructs

What should biotech patent drawings show?

Strong biology patent figures help a reader understand an invention without relying on guesswork. For sequence-based inventions, the drawing may show where a promoter, coding sequence, linker, signal peptide, terminator, restriction site, mutation, or homology arm sits within a construct. For a cell-based invention, it may show how components interact in a pathway or how a vector is introduced into a host cell.

The drawings do not replace the written description or sequence listing. Instead, they provide a visual map of the claimed subject matter. A good rule is to draw structural relationships and experimental logic, while placing nucleotide or amino-acid sequences in the proper sequence listing format required by the patent office or filing procedure.

What are common biotech patent drawing examples?

1. Plasmid map drawing

A plasmid map drawing commonly uses a circular vector with labeled segments arranged around the circle. Typical labels include an origin of replication, promoter, insert, selectable marker, antibiotic-resistance gene, terminator, and restriction sites. Arrows can show directionality, but the figure should remain clean and technically consistent.

For example, a vector might show a CMV promoter upstream of a codon-optimized coding sequence, followed by a polyA signal; a separate resistance marker may be transcribed in the opposite direction. The figure should not imply a physical arrangement that contradicts the specification.

2. Linear expression cassette diagram

A linear construct figure often works better than a circular map when the claim focuses on an insert or expression cassette. A simple left-to-right arrangement can show: promoter—5′ untranslated region—signal peptide—coding sequence—linker—tag—terminator. Each element should use a consistent shape, hatch pattern, or label style.

This type of figure is especially useful when comparing variants. For instance, Construct A may contain a wild-type promoter, Construct B may contain a modified promoter, and Construct C may add an enhancer. Align the three constructs vertically so differences are visually obvious.

3. Gene-editing or knock-in construct

A gene-editing figure may show a target genomic locus, guide RNA target site, donor template, homology arms, and edited locus. Arrows or brackets can distinguish the native locus from the donor and final integrated product. If the invention depends on relative placement, include approximate positions, exon labels, or breakpoint indicators, but avoid unsupported dimensions.

4. Sequence relationship figures

Sequence listing figures should not simply paste long sequence text into a drawing. Instead, use schematic bars or aligned blocks to show variants, conserved domains, deletions, substitutions, fusion points, primer-binding regions, or homology percentages. A short motif may be labeled directly when it is essential to understanding the figure; the full sequence can be identified by a sequence identifier in the formal sequence listing.

5. Pathway, cell, and method figures

Some biotech inventions require a cellular context. A pathway figure might show a receptor, engineered enzyme, metabolite, reporter, or feedback loop. A method figure could use numbered steps: obtain cells, deliver vector, select edited cells, expand culture, and measure expression. Numbering is particularly helpful when the detailed description refers repeatedly to individual steps.

Step-by-step workflow for preparing a biotech patent figure

1. Identify the inventive point. Decide whether the reader must understand a vector, sequence variant, cell pathway, manufacturing step, or experimental result.
2. Separate drawings from sequence data. Use sequence listing figures only for visual relationships; put full sequences in the required sequence listing rather than embedding them as drawing text.
3. Inventory every labeled element. List promoters, genes, terminators, markers, restriction sites, primers, domains, and directionality before drawing.
4. Choose the right view. Use a circular map for a complete vector, a linear schematic for an insert or cassette, and aligned bars for variant comparisons.
5. Use consistent symbols. Promoters, coding regions, terminators, homology arms, and other repeated features should use the same shape or fill treatment throughout.
6. Check orientation and scale. Arrows must show transcription direction accurately. If elements are not drawn to scale, state that in the brief description of the drawings.
7. Minimize text. Labels should identify components, but dense paragraphs or sequence strings can make a figure look like a specification page rather than a patent drawing.
8. Review support and naming. Every reference character, abbreviation, and construct name should match the specification and sequence listing.
9. Prepare a formal drawing review. Confirm margins, numbering, line quality, shading, photograph use, and other formal requirements with the responsible patent professional.

Concrete example: engineered fusion protein construct

Suppose the invention is an expression construct for a fusion protein. A useful biology patent figure could contain three aligned views. The top view shows the circular plasmid with an origin of replication, promoter, fusion-protein insert, terminator, and selectable marker. The middle view expands the insert as a linear cassette: promoter, signal peptide, first binding domain, flexible linker, second binding domain, and polyA signal. The bottom view shows the translated protein as labeled domains connected by the linker.

If three variants are disclosed, each variant should use the same backbone and domain order, with only the changed feature highlighted. For example, Variant 1 has a short linker, Variant 2 has a long glycine-serine linker, and Variant 3 replaces the signal peptide. This visual comparison can communicate the experimental design more clearly than describing each construct only in prose.

A supporting sequence listing would identify the relevant nucleic acid and amino-acid sequences by sequence number. The drawing can refer to those identifiers where needed, but should not rely on tiny sequence text that becomes illegible in print or PDF viewing.

Common mistakes to avoid

• Pasting long sequences into drawings: Sequence data should normally appear in the formal sequence listing, not as crowded sequence listing figures.
• Inconsistent construct orientation: A promoter shown upstream in one view and downstream in another creates ambiguity and may weaken clarity.
• Using color as the only distinction: Patent drawings are commonly reproduced in black and white; use patterns, labels, spacing, or shape differences instead.
• Overloading a plasmid map: Do not label every base pair, primer, and minor feature on one figure if the invention depends on only a few elements.
• Mixing trademarks, marketing language, and results claims: Keep the figure technical and neutral rather than promotional.
• Importing low-resolution laboratory images: Gel images, microscopy images, and screenshots may require special handling and are often less effective than clean schematic diagrams.
• Failing to coordinate numbering: Reference numerals and labels must match the detailed description consistently.

Tools such as PatentDraw can help turn rough construct sketches and laboratory diagrams into organized working drafts suitable for collaborative review. Even so, AI output is a working draft and requires human technical and professional review. A patent agent or attorney should check claim support, inventorship, sequence-listing requirements, and formal drawing rules before filing.

Frequently asked questions

Can I include a DNA or protein sequence in a patent drawing?

Short labels or motifs may appear when necessary to explain a figure, but full nucleotide or amino-acid sequences are usually submitted in a formal sequence listing rather than as drawings. Use the drawing to show arrangement, mutations, domains, primers, or relationships. The filing rules for the relevant patent office should control the final format.

What is the best figure format for a plasmid invention?

A circular plasmid map is usually best for showing the complete vector, while a linear schematic is clearer for an insert, expression cassette, or variant comparison. Use arrows to show directionality and keep labels consistent across all views. If features are not proportional, say that the drawing is not to scale.

Do patent drawings for biotech inventions need color?

Generally, no. Most patent drawings should be understandable in black and white through line weight, shape, hatching, brackets, and labels. Color may be permitted in limited circumstances, but it should not be the only way to distinguish components because reproduction and filing requirements can vary.